Shire downgraded to Market Perform as spread narrows at Bernstein
Bernstein analyst Aaron Gal downgraded Shire (SHPG) to Market Perform from Outperform. The analyst notes that he current controversy on Shire is the risk/reward into the closing of the Takeda (TKPYY) acquisition, and over the past few weeks deal spread narrowed, and the fundamentals have gotten a bit tougher in ADHD, HAE and Hemophilia.https://thefly.com/landingPageNews.php?id=2785113
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.